The FDA has granted fast-track approval to the drug telisotuzumab vedotin (sold as Emrelis) as a first-of-its-kind treatment for certain people who have non-squamous non-small-cell lung cancer.

Study Published in a special issue of International Journal of Molecular Sciences Confirms Test's Ability to Distinguish ...

Dr. Chao H. Huang explains his skepticism regarding a recent study that linked chronic pain to significantly higher lung ...

A recent study has uncovered an unexpected connection between our diets and the progression of lung cancer, specifically a ...

Cells expressing the basal cell marker KRT5 have been fluorescently labelled and can be seen spreading throughout the bronchial tree The ‘cell of origin’ of the second most common lung cancer and the ...

The U.S. Food and Drug Administration (FDA) on Monday cleared the amendment to Lantern Pharma Inc.’s (NASDAQ:LTRN) ...

Morgan Rynor reports there are genetic mutations that could indicate an elevated risk for colon, lung, rectal, prostate and other cancers. Depending on the marker, there are different routes a patient ...

The new screening panel offers gender-specific diagnostics and hereditary risk assessment aimed at improving early cancer ...

Grey’s Anatomy star Kate Walsh is partnering with GRAIL to advocate for more multi-cancer early detection testing in a ...

Cancer care has changed dramatically over the last decade. As opposed to a "one-size-fits-all" approach, treatment today is ...

Cancer is cruel. It doesn’t care that you’re only 37, that you're the mother of a little girl who is your entire world. So Elissa vowed to fight.